Success Stories: EB-1A Approved for a Medical Laboratory Scientist in Indiana in the Field of Medicinal Chemistry
Client’s Testimonial:
Thank you so much for your help! Your service was excellent and prompt.
We Received EB1-A (Alien of Extraordinary Ability) Approval on December 2nd for a Medical Laboratory Scientist in Indiana in the Field of Medicinal Chemistry(Approval Notice)
Position at the Time of Case Filing: Medical Laboratory Scientist
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Indiana
Approval Notice Date: December 2nd, 2014
Processing Time: 4 Months, 21 Days
In this case, the client that we had the pleasure of working with was a Medical Laboratory Scientist from India in the field of Medicinal Chemistry. His work has focused specifically on the design and synthesis of allosteric inhibitors of thrombin and on chemically improving the pharmacological properties of irreversible vitamin D receptor (VDR)-coactivator inhibitors. His work had resulted in 18 peer-reviewed scientific articles and numerous presentations at national and international conferences. At the time that his case was filed, his publications had been cited at least 109 times by researchers around the world, serving as apparent and objective evidence of his major influence and impact on the field of endeavor, in addition to his sustained international acclaim. He had also reviewed 27 manuscripts for at least 8 distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “[Client]’s research proffers tremendous benefits to the USA. According to the latest data, the current market for nuclear-receptor targeted drugs represents about 15% of the total global pharmaceutical market. [Client]’s work has demonstrated innovative methods for hindering the interactions between VDR and its coactivators, resulting in cancer regression and prevention. Given that 600,000 Americans are expected to die of cancer each year, this research is clearly a matter of life or death for many.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Medicinal Chemistry, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 4 months and 21 days.